Skip to main content

Table 2 Studies reporting on HPV prevalence in ovarian cancer tissue

From: The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis

Author & publication year Detection method HPV genotypes found Number of cases of EOC Number of HPV positive cases HPV prevalence (%)
Ingerslev et al. (2016) [28] PCR 18 191 1 0.5
Al-Shabanah et al. (2013) [29] PCR 16,18,45 100 42 42.0
Malisic et al. (2012) [30] PCR 16 54 4 7.4
Bilyk et al. (2011) [31] PCR 16,18 53 9 16.9
Idahl et al. (2010) [18] PCR   52 0 0
Giordano et al. (2008) [32] PCR Not specified 50 1 2.0
Wentzensen et al. (2008) [19] PCR   74 0 0
Atalay et al. (2007) [33] PCR 16,33 94 8 8.5
Quirk et al. (2006) [20] PCR   16 0 0
Yang et al. (2003) [34] PCR 16,18 56 19 33.9
Ip et al. (2002) [35] PCR 16,18 60 6 10
Li et al. (2002) [36] PCR Not specified 39 26 66.6
Antilla et al. (1999) [21] PCR   98 0 0
Chen et al. (1999) [22] PCR   20 0 0
Strickler et al. (1998) [37] ELISA 16 16 1 6.2
Zimna et al. (1997) [38] PCR 18 18 7 38.8
Anwar et al. (1996) [23] PCR   3 0 0
Runnebaum et al. (1995) [24] PCR   26 0 0
Trottier et al. (1995) [25] PCR   22 0 0
Lai et al. (1994) [39] PCR 16,18 18 11 61.1
Beckmann et al. (1991) [26] PCR   18 0 0
de Villiers (1986) [27] Southern blot hybridisation   7 0 0